Regulators of the European Union are set to conditionally approve the merger of Anheuser-Busch InBev-SABMiller.
Reuters reported on Friday that the world’s largest brewer, Anheuser Busch Inbev is all set to get a conditional approval from EU for its multi-billion dollar takeover of its London-based rival, SAB Miller after accepting substantial asset sales.
AB InBev, which is the maker of Budweiser, Corona, and Stella Artois, is seeking to increase its presence in Africa and in Latin American regions in order to offset its not-so-stronger markets such as the US, where the drinkers are moving away from mainstream lagers toward craft brews and cocktails.
Previously, European Commission had announced that it will give its decision on the merger deal on May 24. In order to get the approval, the brewing giant had informed European regulators regarding its plans of offloading SABMiller’s premium European brands, Peroni and Grolsch, to tackle the regulatory issues.
The brewing company is selling these beer assets because of its already thick presence in the region through its brands such as Stella Artois, Corona, and other A-B beers.
Full Content: Business Finance News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Chamber of Commerce Sues to Overturn FTC Non-Compete Ban
Apr 24, 2024 by
CPI
FTC Chief Warns of Healthcare Price Fixing Risks Amid Tech Advancements
Apr 24, 2024 by
CPI
Amazon’s Investment in Anthropic Faces Antitrust Scrutiny
Apr 24, 2024 by
CPI
Italian Antitrust Authority Fines Amazon €10 Million for Unfair Trade Practices
Apr 24, 2024 by
CPI
Tuta Mail Raises Alarm Over Google Search Ranking Plunge Amidst DMA Rollout
Apr 24, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI